Trending Now
Lucid Motors (LCID) could be a falling knife for retail traders
The stock of Lucid (NASDAQ:LCID) saw a significant increase on Friday, with the price nearly doubling before trading was halted. The stock...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Quantum Corporation (QMCO): Revolutionizing Data Protection with the DXi9200 to Strengthen...
Quantum Corporation (NASDAQ: QMCO), a leader in end-to-end data management solutions for the AI era, is making waves in the tech sector...
MAKE IT MODERN
LATEST REVIEWS
PDS Biotechnology Corporation’s (NASDAQ: PDS) VERSATILE-002 Study in advanced HPV-related Head...
PDS Biotechnology Corporation (NASDA: PDS) has announced that its VERSATILE-002 second phase study of advanced human papillomavirus (HPV)-related head and neck cancer treatment attained...
MAKE IT MODERN
PERFORMANCE TRAINING
C3.ai Inc (NYSE:AI) gains over 30% in 3 days on strength in ChatGPT/AI names
ChatGPT has taken the world by storm and Buzzfeed (BZFD) got the party started with a ChatGPT PR last week which sent...
Novavax Inc. (NASDAQ:NVAX) Shares Jump Following CEPI’s $384 Million Cash Infusion For Covid-19 Vaccine...
Novavax Inc. (NASDAQ:NVAX) has been performing poorly in recent times, but its stock received a boost recently following a $384 million from the Coalition...
Auris Medical Holdings Ltd. (NASDAQ:EARS) Reports Positive AM-301 In Vitro Study Data Against SARS-CoV-2
Auris Medical Holdings Ltd. (NASDAQ:EARS) has announced positive efficacy results from AM-301 in vitro study. The company’s affiliate Altamira Medica is developing AM-301 as...
Freeline Therapeutics Holdings (NASDAQ: FRLN) Updates Plans For Clinical Development of FLT190
Freeline Therapeutics Holdings (NASDAQ: FRLN) has updated its FLT190 timelines and plans for clinical development. The therapy treats Fabry’s disease. Fairy is a genetic...
Reason why IBRX could reward early traders and investors
ImmunityBio, Inc. (NASDAQ: IBRX) recently made waves in the medical community with its pioneering immunotherapy, ANKTIVA® (nogapendekin alfa inbakicept-pmln), marking a significant...
MAKE IT MODERN
